A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback